2017
DOI: 10.1007/978-3-319-55231-6_40
|View full text |Cite
|
Sign up to set email alerts
|

Using India Ink as a Sensor for Oximetry: Evidence of its Safety as a Medical Device

Abstract: Clinical EPR spectroscopy is emerging as an important modality, with the potential to be used in standard clinical practice to determine the extent of hypoxia in tissues and whether hypoxic tissues respond to breathing enriched oxygen during therapy. Oximetry can provide important information useful for prognosis and to improve patient outcomes. EPR oximetry has many potential advantages over other ways to measure oxygen in tissues, including directly measuring oxygen in tissues and being particularly sensitiv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(3 citation statements)
references
References 39 publications
0
3
0
Order By: Relevance
“…EPR oximetry requires the respective implantation of an exogenous particulate or the injection of a soluble agent into the tumor to quantify pO 2 (132)(133)(134)140). Detection is therefore limited to superficial tumors; however investigations to assess and put forth safer and more informative oxygen sensors that can work at any tissue depth are ongoing (133,(141)(142)(143), and some are being applied in clinical studies (144). Regarding EPRI, the recent introduction of nontoxic, water-soluble, and biocompatible paramagnetic probes could lead to its clinical translation, enabling the non-invasive, real-time quantification of pO 2 in a three-dimensional format (134,140,145).…”
Section: Detection Of Hypoxia In the Context Of Vascular Normalizationmentioning
confidence: 99%
“…EPR oximetry requires the respective implantation of an exogenous particulate or the injection of a soluble agent into the tumor to quantify pO 2 (132)(133)(134)140). Detection is therefore limited to superficial tumors; however investigations to assess and put forth safer and more informative oxygen sensors that can work at any tissue depth are ongoing (133,(141)(142)(143), and some are being applied in clinical studies (144). Regarding EPRI, the recent introduction of nontoxic, water-soluble, and biocompatible paramagnetic probes could lead to its clinical translation, enabling the non-invasive, real-time quantification of pO 2 in a three-dimensional format (134,140,145).…”
Section: Detection Of Hypoxia In the Context Of Vascular Normalizationmentioning
confidence: 99%
“…EPR oximetry in humans has thus far been conducted using probes composed of ink particulates; these probes are limited in that they can only measure oxygen if placed within a few mm of the skin surface (9,10). Although ink particulates are tolerated well, this depth limitation hampers their clinical utility vis a vis human malignancies (11). In contrast, the OxyChip probe, a small paramagnetic oxygen sensor composed of oxygen-sensing lithium octa-n-butoxynaphthalocyanine (LiNc-BuO) crystals embedded in a biocompatible polymer (12), can measure pO 2 up to a depth of at least 1.5 cm.…”
Section: Introductionmentioning
confidence: 99%
“…However, changes in circulating factors in response to changes in HIF-1a-regulated genes may be useful as non-invasive indicators of tissue hypoxia. HIF-1a directly regulates prolyl-4-hydroxylase a1 (P4HA1) expression, catalyzes proline hydroxylation at X-Pro-Gly (X-P-G) triplets, which plays a critical role in collagen biogenesis [18,19] and is essential for normal collagen folding and stability during tumor remodeling [20][21][22]. Other molecules containing collagen-like sequences can also serve as substrates for P4H activity, including bradykinin (BK), a peptide involved in blood pressure regulation and inflammation [23].…”
Section: Introductionmentioning
confidence: 99%